Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, retail drugstore operator Rite Aid (NYSE: RAD) has received the dreaded one-star ranking.

With that in mind, let's take a closer look at Rite Aid's business and see what CAPS investors are saying about the stock right now.

Rite Aid facts

Headquarters (founded) Camp Hill, Pa. (1927)
Market Cap $1.1 billion
Industry Drug retail
Trailing-12-Month Revenue $26.1 billion
Management CEO John Standley
CFO Frank Vitrano
Return on Equity (average, past 3 years) 3.5%
Cash / Debt $162.3 million / $6.4 billion
Competitors CVS Caremark
Walgreen
Wal-Mart Stores

Sources: S&P Capital IQ and Motley Fool CAPS.

On CAPS, 17% of the 977 members who have rated Rite Aid believe the stock will underperform the S&P 500 going forward.

A few months ago, one of those Fools, All-Star BuffettJunior1, succinctly summed up the bear case for our community:

This is a slow growth business that is consistently losing money. The company has very little cash on hand and about $6.2 billion in long-term debt. ... Now, I don't know about you people but to me this stock seems grossly overvalued. In fact, I am willing to bet good money that this company won't be around 5 years from now. The company is taking on an ever increasing amount of debt every year and is struggling to cover its interest expense. This cannot go on forever. ... This stock might do well in the short-term; however, in the long run I can almost guarantee that it will become worthless.

If you want market-thumping returns, you need to protect your portfolio from any undue risk. Luckily, we've found another retailer we are incredibly excited about -- excited enough to dub it "The Motley Fool's Top Stock for 2012." We have compiled a special free report for investors to uncover this stock today. The report is 100% free, but it won't be here forever, so click here to access it now.

Want to see how well (or not so well) the stocks in this series are performing? Follow the new TrackPoisedTo CAPS account.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis -- even one of our own -- helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.